Dataset from Safety, Tolerability and Efficacy of PfSPZ Vaccine Administered by Direct Venous Inoculation (DVI) to Healthy Children and Infants 5 Months Through 9 Years of Age Living in an Area of High Malaria Transmission in Western Kenya: Age De-escalation and Dose Escalation and a Double Blind, Randomized Placebo-Controlled Trial for Safety and Efficacy

This study will be conducted in Siaya County in Nyanza Province, western Kenya. Healthy
children aged 5 months through 9 years of age living within approximately 10 km of the study
clinic(s) (Siaya County Referral Hospital, or Wagai dispensary, a government health facility
in Wagai division) will be eligible for participation in Part 1; healthy infants aged 5
months - 12 months inclusive will be eligible for Part 2.